Related Experiment Video

Updated: Aug 5, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Transforming growth factor-beta in benign and malignant prostate

C Lee1, S M Sintich, E P Mathews

  • 1Department of Urology, Northwestern University Medical School, Chicago, Illinois 60611, USA. c-lee7@nwu.edu

The Prostate
|May 27, 1999
PubMed
Abstract

Insights

Transforming growth factor-beta (TGF-beta) plays a dual role in prostate cancer. While inhibiting benign growth, it promotes malignant progression by suppressing immune function and enhancing tumor growth.

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • Reviews the cellular functions of transforming growth factor-beta (TGF-beta) in both benign and malignant prostate conditions.
  • Highlights TGF-beta's role in regulating cell growth, differentiation, and apoptosis in the prostate.

Purpose of the Study:

  • To elucidate the distinct mechanisms of TGF-beta action in benign prostatic hyperplasia versus prostate cancer.
  • To investigate the impact of TGF-beta receptor expression and production on prostate cancer progression.

Main Methods:

  • Analysis of TGF-beta's paracrine and autocrine signaling pathways in prostate epithelial and stromal cells.
  • Examination of changes in TGF-beta receptor expression and TGF-beta production during malignant transformation.
  • Utilized a rat prostate cancer model to assess the role of TGF-beta in tumor immunity and progression.

Main Results:

  • In benign conditions, TGF-beta inhibits proliferation and induces apoptosis in epithelia, and promotes smooth muscle differentiation in stroma.
  • Malignant transformation involves loss of functional TGF-beta receptors and overproduction of TGF-beta.
  • Overproduced TGF-beta promotes extracellular matrix production, angiogenesis, and immune suppression, enhancing prostate cancer tumorigenicity.

Conclusions:

  • TGF-beta's immunosuppressive effect is a primary driver of prostate cancer progression.
  • Future therapeutic strategies should target TGF-beta signaling pathways for prostate cancer eradication.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts09:43

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts

Published on: August 1, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...